Intuitive Surgical (ISRG) Tops Q2 EPS by 59c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
Go back to Intuitive Surgical (ISRG) Tops Q2 EPS by 59c
July 22, 2015 7:09 AM EDT
Jefferies analyst Imron Zafar reiterated a Buy rating and boosted its price target on Intuitive Surgical (NASDAQ: ISRG) to $675.00 (from $616.00) following strong Q2 results.
Zafar commented, "2Q highlights: (1) 14% procedure growth, well ahead of our 10% and fueled by general surgery/international coupled with normalizing... More
July 22, 2015 7:07 AM EDT
(Updated - July 22, 2015 9:33 AM EDT)
Canaccord Genuity upgraded Intuitive Surgical (NASDAQ: ISRG) from Hold to Buy with a price target of $615.00 (from $517.00). The change follows strong Q2 results. Analyst Jason Mills said he is now much more confident in the company's fundamentals.
"Procedure growth has accelerated in three of the last four quarters (and 4Q was still +10%), which we think portends ISRG has turned a corner in this all important recurring revenue segment legacy procedure (dvP, dvH)... More
July 22, 2015 6:50 AM EDT
Leerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on Intuitive Surgical (NASDAQ: ISRG) to $600.00 (from $590.00) following a 'hat trick' in Q2.
Newitter commented, "ISRG's 2Q sales/EPS beat was highlighted by better than expected system placements,... More
